Cyclerion Therapeutics Stock Price Prediction
| CYCN Stock | USD 3.05 0.45 12.86% |
Oversold Vs Overbought
46
Oversold | Overbought |
Cyclerion Therapeutics stock price prediction is an act of determining the future value of Cyclerion Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Cyclerion Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Cyclerion Therapeutics and does not consider all of the tangible or intangible factors available from Cyclerion Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Cyclerion Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Cyclerion Therapeutics' stock price prediction:Wall Street Target Price 4 | Quarterly Revenue Growth 0.141 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Cyclerion Therapeutics based on different types of headlines from major news networks to social media. The Cyclerion stock price prediction module provides an analysis of price elasticity to changes in media outlook on Cyclerion Therapeutics over a specific investment horizon. Using Cyclerion Therapeutics hype-based prediction, you can estimate the value of Cyclerion Therapeutics from the perspective of Cyclerion Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Cyclerion Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Cyclerion Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Cyclerion because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Cyclerion Therapeutics after-hype prediction price | USD 3.05 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cyclerion |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cyclerion Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cyclerion Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Cyclerion Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cyclerion Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cyclerion Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cyclerion Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Cyclerion Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cyclerion Therapeutics' historical news coverage. Cyclerion Therapeutics' after-hype downside and upside margins for the prediction period are 0.15 and 10.58, respectively. We have considered Cyclerion Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cyclerion Therapeutics is very risky at this time. Analysis and calculation of next after-hype price of Cyclerion Therapeutics is based on 3 months time horizon.
Cyclerion Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Cyclerion Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cyclerion Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cyclerion Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.04 | 7.53 | 0.00 | 0.02 | 3 Events / Month | 15 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.05 | 3.05 | 0.00 |
|
Cyclerion Therapeutics Hype Timeline
Cyclerion Therapeutics is currently traded for 3.05. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.02. Cyclerion is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.04%. %. The volatility of related hype on Cyclerion Therapeutics is about 1398.68%, with the expected price after the next announcement by competition of 3.07. About 21.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.81. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cyclerion Therapeutics recorded a loss per share of 5.39. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 16th of May 2023. Given the investment horizon of 90 days the next forecasted press release will be in about 3 days. Check out Cyclerion Therapeutics Basic Forecasting Models to cross-verify your projections.Cyclerion Therapeutics Related Hype Analysis
Having access to credible news sources related to Cyclerion Therapeutics' direct competition is more important than ever and may enhance your ability to predict Cyclerion Therapeutics' future price movements. Getting to know how Cyclerion Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cyclerion Therapeutics may potentially react to the hype associated with one of its peers.
Cyclerion Therapeutics Additional Predictive Modules
Most predictive techniques to examine Cyclerion price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cyclerion using various technical indicators. When you analyze Cyclerion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cyclerion Therapeutics Predictive Indicators
The successful prediction of Cyclerion Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cyclerion Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cyclerion Therapeutics based on analysis of Cyclerion Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cyclerion Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cyclerion Therapeutics's related companies. | 2010 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 0.26 | 0.0219 | 0.0252 | 0.0239 | Days Of Inventory On Hand | 717.63 | 4.5K | 4.1K | 2.1K |
Story Coverage note for Cyclerion Therapeutics
The number of cover stories for Cyclerion Therapeutics depends on current market conditions and Cyclerion Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cyclerion Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cyclerion Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Cyclerion Therapeutics Short Properties
Cyclerion Therapeutics' future price predictability will typically decrease when Cyclerion Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cyclerion Therapeutics often depends not only on the future outlook of the potential Cyclerion Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cyclerion Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.3 M | |
| Cash And Short Term Investments | 7.6 M |
Check out Cyclerion Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Cyclerion Stock, please use our How to Invest in Cyclerion Therapeutics guide.Note that the Cyclerion Therapeutics information on this page should be used as a complementary analysis to other Cyclerion Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Cyclerion Stock analysis
When running Cyclerion Therapeutics' price analysis, check to measure Cyclerion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclerion Therapeutics is operating at the current time. Most of Cyclerion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cyclerion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclerion Therapeutics' price. Additionally, you may evaluate how the addition of Cyclerion Therapeutics to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Cyclerion Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclerion Therapeutics. If investors know Cyclerion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclerion Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.39) | Revenue Per Share 0.586 | Quarterly Revenue Growth 0.141 | Return On Assets (0.38) | Return On Equity (1.16) |
The market value of Cyclerion Therapeutics is measured differently than its book value, which is the value of Cyclerion that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclerion Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cyclerion Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclerion Therapeutics' market value can be influenced by many factors that don't directly affect Cyclerion Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclerion Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cyclerion Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclerion Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.